What does the FDA actually mean by CGMP?
Recommendation

2/3 September 2026
Copenhagen, Denmark
When “Human Error” isn’t enough: Successful Failure Investigation
In the EU, but also in almost all PIC/S countries and at the WHO, Good Manufacturing Practice is referred to as GMP. The US Food and Drug Administration (FDA), however, refers to it as CGMP (formerly also cGMP). But what exactly is behind this? The FDA published a paper entitled "Facts About the Current Good Manufacturing Practices (CGMPs)" on this some time ago.
CGMP refers to FDA regulations on current Good Manufacturing Practice. According to the FDA, the CGMP requirements have been designed so flexibly that each manufacturer can decide for himself how best to implement them. Accordingly, the "C" in CGMP stands for "current", which means that companies must use technologies and systems that are up-to-date to comply with the regulations. Systems and equipment that were "top-of-the-line" 10 or 20 years ago to prevent contamination, mix-ups and errors may be inadequate by today's standards.
The FDA publishes regulations and guidance documents in the Federal Register. The FDA's website also contains links to CGMP regulations, guidance documents and various resources to help drug companies comply with the regulations.
The FDA emphasises that CGMP describes minimum requirements. Modern, comprehensive quality systems and risk management concepts can also go beyond these requirements.
Related GMP News
01.07.2026EMA publishes updated Q&A on EU-US MRA - Veterinary Medicinal Products now fully covered
24.06.2026Reduced Testing a Matter of GMP or Specification?
17.06.2026FDA adopts updated ICH Q8/Q9/Q10 Questions & Answers (R5)
10.06.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated


